UK government announces up to £39 million cash injection for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund

Cutting-edge research initiatives to develop new treatments to tackle antimicrobial resistance (AMR) will receive a cash injection of up to £39 million from the UK government’s Global AMR Innovation Fund (GAMRIF). Of this new funding package, up to £24 million over 4 years has been awarded to bolster the UK’s partnership with CARB-X - a global AMR research initiative - to support the continued…